Rare Discount on Sports-Betting Powerhouse
DraftKings has been one of the major winners of America’s sports-betting boom. But after dropping more than 30% over the past three months, investors are asking whether the selloff reflects genuine weakness, or a rare buying opportunity.
To answer that, it helps to focus on the bigger question: does DraftKings actually have a moat?
» Read more about: Rare Discount on Sports-Betting Powerhouse »
Read More
Can You Retire On UPS?
United Parcel Service has long been one of the world’s most trusted shipping giants, a backbone of global commerce that seems almost untouchable. But in the past half decade, shareholders have felt more turbulence than smooth sailing. The stock is down 46%.
That’s a sobering reality for a company many once viewed as a safe,
» Read more about: Can You Retire On UPS? »
Read More
UnitedHealth Could Get Worse Before It Gets Better
After a punishing first half of the year, UnitedHealth’s latest earnings report delivered another gut punch.
The stock, which had already been cut in half year-to-date by July 31, slid even further following the release.
Between deteriorating fundamentals, mounting regulatory pressure, and a brutal earnings revision, it’s fair to ask whether UnitedHealth finally hit bottom,
» Read more about: UnitedHealth Could Get Worse Before It Gets Better »
Read More
1 Signal That Dutch Bros Could Be a Monster Stock
If you gave up on Dutch Bros after its post-IPO slump, you might be kicking yourself right now. After going public in 2021 and fizzling out soon after, Dutch Bros has staged a remarkable comeback, rising nearly 90% over the past 2 years.
And this rebound isn’t just a flash in the pan.
» Read more about: 1 Signal That Dutch Bros Could Be a Monster Stock »
Read More
AppLovin’s Rally Hits a Rough Patch
After an extraordinary run that sent shares soaring nearly 300% over the past year, AppLovin suddenly lost momentum in early October. The sell-off came as a shock to investors who had watched the ad-tech company become one of Wall Street’s brightest stars.
The trigger was a Bloomberg report revealing that the SEC had opened an investigation into AppLovin’s data-collection practices.
» Read more about: AppLovin’s Rally Hits a Rough Patch »
Read MoreThe Ivy
Which AI Stock Is Best?
If you follow the market’s biggest winners, you already know Alphabet and NVIDIA sit at the center of the AI boom. But despite being lumped together as “AI beneficiaries,” the two companies couldn’t be more different. One is a diversified digital empire with unmatched cash flow. The other is the indispensable hardware supplier powering the AI build-out.
» Read more about: Which AI Stock Is Best? »
Read MoreThe Spotlight
Why Novo May Be the Real Winner in Obesity Drug Boom
For decades, Novo Nordisk was known mainly within the medical community as a quiet Danish powerhouse in diabetes care. Fast-forward to today, and its brand names are practically pop culture references. Wegovy and Ozempic have become synonymous with rapid weight loss, with late-night comedians, TikTok influencers, and even Hollywood scripts weaving them into conversation. Yet the company’s stock,
» Read more about: Why Novo May Be the Real Winner in Obesity Drug Boom »
Read MoreThe Daily
Getting Social Security and Working? Here Are the 2026 Rules Changes You Must Know
Some retirees may continue working well into their 60s, either by choice or necessity. If you want to retire comfortably,